DE3585252D1
(de)
|
1984-07-06 |
1992-03-05 |
Fisons Plc |
Benzimidazole, und verfahren zu deren herstellung, deren formulierung und verwendung als magensaeuresekretionshemmende verbindungen.
|
CA1327010C
(fr)
*
|
1986-02-13 |
1994-02-15 |
Tadashi Makino |
Compositions pharmaceutiques contenant un compose anti-ulcereux de type benzimidazole et sa production
|
US5433959A
(en)
|
1986-02-13 |
1995-07-18 |
Takeda Chemical Industries, Ltd. |
Stabilized pharmaceutical composition
|
US6749864B2
(en)
|
1986-02-13 |
2004-06-15 |
Takeda Chemical Industries, Ltd. |
Stabilized pharmaceutical composition
|
CA1276017C
(fr)
*
|
1986-02-13 |
1990-11-06 |
Takeda Chemical Industries, Ltd. |
Derives de sulfenamide, et leur production
|
DK171989B1
(da)
*
|
1987-08-04 |
1997-09-08 |
Takeda Chemical Industries Ltd |
Fremgangsmåde til fremstilling af 2-(2-pyridylmethylsulfinyl)-benzimidazoler
|
JPH03504497A
(ja)
*
|
1988-05-25 |
1991-10-03 |
ビイク グルデン ロンベルク ヒエーミツシエ フアブリーク ゲゼルシヤフト ミツト ベシユレンクテル ハフツング |
新規フルオルアルコキシ化合物
|
JP2536173B2
(ja)
*
|
1988-08-18 |
1996-09-18 |
武田薬品工業株式会社 |
注射剤
|
US5223515A
(en)
*
|
1988-08-18 |
1993-06-29 |
Takeda Chemical Industries, Ltd. |
Injectable solution containing a pyridyl methylsulfinylbenzimidazole
|
AT391693B
(de)
*
|
1988-11-15 |
1990-11-12 |
Cl Pharma |
Verfahren zur herstellung von 3-5-dimethyl-4methoxypyridinderivaten sowie neues zwischenprodukt hierfuer
|
SE8804629D0
(sv)
*
|
1988-12-22 |
1988-12-22 |
Ab Haessle |
New therapeutically active compounds
|
EG19302A
(en)
*
|
1988-12-22 |
1994-11-30 |
Haessle Ab |
Compound with gastric acid inhibitory effect and process for its preparation
|
SE8804628D0
(sv)
|
1988-12-22 |
1988-12-22 |
Ab Haessle |
New compounds
|
ATE114114T1
(de)
*
|
1989-02-10 |
1994-12-15 |
Takeda Chemical Industries Ltd |
Verwendung von benzimidazol-derivaten als antibakterielle mittel.
|
US4965269A
(en)
*
|
1989-12-20 |
1990-10-23 |
Ab Hassle |
Therapeutically active chloro substituted benzimidazoles
|
US5274099A
(en)
*
|
1989-12-20 |
1993-12-28 |
Aktiebolaget Hassle |
Therapeutically active fluoro substituted benzimidazoles
|
US5049674A
(en)
*
|
1989-12-20 |
1991-09-17 |
Aktiebolaget Hassle |
Therapeutically active fluoro substituted benzimidazoles
|
EP0481764B1
(fr)
|
1990-10-17 |
2000-03-29 |
Takeda Chemical Industries, Ltd. |
Dérivés de pyridine, leur préparation et utilisation
|
TW209174B
(fr)
|
1991-04-19 |
1993-07-11 |
Takeda Pharm Industry Co Ltd |
|
NZ244301A
(en)
*
|
1991-09-20 |
1994-08-26 |
Merck & Co Inc |
Preparation of 2-pyridylmethylsulphinylbenzimidazole and pyridoimidazole derivatives from the corresponding sulphenyl compounds
|
ES2036948B1
(es)
*
|
1991-11-21 |
1994-09-01 |
Genesis Para La Investigacion |
Procedimiento de obtencion de compuestos derivados de piridina.
|
KR0144793B1
(ko)
*
|
1992-07-08 |
1998-07-15 |
제임스 클리프튼 보올딩 |
돼지에서 위궤양을 완화시키기 위한 벤즈이미다졸
|
WO1994002141A1
(fr)
*
|
1992-07-28 |
1994-02-03 |
Astra Aktiebolag |
Injection et trousse d'injection contenant de l'omeprazole et ses analogues
|
JPH08507054A
(ja)
*
|
1993-02-17 |
1996-07-30 |
ビイク グルデン ロンベルク ヒェーミッシェ ファブリーク ゲゼルシヤフト ミツト ベシユレンクテル ハフツング |
ヘリコバクターバクテリアに対抗するための置換されたヘテロアリールアルキルチオピリジン
|
ES2060541B1
(es)
*
|
1993-02-26 |
1995-11-16 |
Vinas Lab |
Nuevo procedimiento para la sintesis de un derivado de 2-(2-piridilmetilsufinil) bencimidazol, y nuevos productos intermedios obtenidos con el mismo.
|
ES2063705B1
(es)
*
|
1993-06-14 |
1995-07-16 |
S A L V A T Lab Sa |
Intermedio para la sintesis de lansoprazol y su procedimiento de obtencion.
|
TW280770B
(fr)
|
1993-10-15 |
1996-07-11 |
Takeda Pharm Industry Co Ltd |
|
US5374730A
(en)
*
|
1993-11-04 |
1994-12-20 |
Torcan Chemical Ltd. |
Preparation of omeprazole and lansoprazole
|
US5502195A
(en)
*
|
1993-11-04 |
1996-03-26 |
Slemon; Clarke |
Sulfoxide-carboxylate intermediates of omeprazole and lansoprazole
|
CN1048980C
(zh)
*
|
1994-03-29 |
2000-02-02 |
广东汕头鮀滨化学药业总公司 |
一种新的吡啶衍生物及其制备方法和应用
|
SE9402431D0
(sv)
*
|
1994-07-08 |
1994-07-08 |
Astra Ab |
New tablet formulation
|
GB9423968D0
(en)
*
|
1994-11-28 |
1995-01-11 |
Astra Ab |
Resolution
|
SE9500422D0
(sv)
*
|
1995-02-06 |
1995-02-06 |
Astra Ab |
New oral pharmaceutical dosage forms
|
SE9500478D0
(sv)
*
|
1995-02-09 |
1995-02-09 |
Astra Ab |
New pharmaceutical formulation and process
|
US5708017A
(en)
*
|
1995-04-04 |
1998-01-13 |
Merck & Co., Inc. |
Stable, ready-to-use pharmaceutical paste composition containing proton pump inhibitors
|
HRP960232A2
(en)
*
|
1995-07-03 |
1998-02-28 |
Astra Ab |
A process for the optical purification of compounds
|
US5824339A
(en)
*
|
1995-09-08 |
1998-10-20 |
Takeda Chemical Industries, Ltd |
Effervescent composition and its production
|
DK1308159T3
(da)
*
|
1995-09-21 |
2005-02-14 |
Pharma Pass Ii Llc |
Farmaceutisk sammensætning indeholdende en syre-labil omeprazol og fremgangsmåde til fremstilling deraf
|
SE521100C2
(sv)
*
|
1995-12-15 |
2003-09-30 |
Astra Ab |
Förfarande för framställning av en bensimidazolförening
|
US5840737A
(en)
|
1996-01-04 |
1998-11-24 |
The Curators Of The University Of Missouri |
Omeprazole solution and method for using same
|
US6699885B2
(en)
*
|
1996-01-04 |
2004-03-02 |
The Curators Of The University Of Missouri |
Substituted benzimidazole dosage forms and methods of using same
|
US6489346B1
(en)
*
|
1996-01-04 |
2002-12-03 |
The Curators Of The University Of Missouri |
Substituted benzimidazole dosage forms and method of using same
|
US6645988B2
(en)
*
|
1996-01-04 |
2003-11-11 |
Curators Of The University Of Missouri |
Substituted benzimidazole dosage forms and method of using same
|
SE9600070D0
(sv)
|
1996-01-08 |
1996-01-08 |
Astra Ab |
New oral pharmaceutical dosage forms
|
US8071128B2
(en)
|
1996-06-14 |
2011-12-06 |
Kyowa Hakko Kirin Co., Ltd. |
Intrabuccally rapidly disintegrating tablet and a production method of the tablets
|
US6380222B2
(en)
|
1996-10-11 |
2002-04-30 |
Astrazeneca Ab |
Use of an H+, K+-atpase inhibitor in the treatment of nasal polyps
|
TW385306B
(en)
*
|
1996-11-14 |
2000-03-21 |
Takeda Chemical Industries Ltd |
Method for producing crystals of benzimidazole derivatives
|
EP0983263A1
(fr)
*
|
1997-05-30 |
2000-03-08 |
Dr. Reddy's Research Foundation |
Nouveaux benzimidazoles utilises comme agents antiulcereux, leur procede de preparation et compositions pharmaceutiques les contenant
|
WO1999004816A1
(fr)
|
1997-07-25 |
1999-02-04 |
Byk Gulden Lomberg Chemische Fabrik Gmbh |
Inhibiteur de la pompe a protons en combinaison therapeutique avec des substances antibacteriennes
|
SE9704870D0
(sv)
|
1997-12-22 |
1997-12-22 |
Astra Ab |
New pharmaceutical formulation I
|
CA2323680C
(fr)
|
1998-05-18 |
2007-05-22 |
Takeda Chemical Industries, Ltd. |
Comprimes se desintegrant dans la bouche
|
ZA9810765B
(en)
*
|
1998-05-28 |
1999-08-06 |
Ranbaxy Lab Ltd |
Stable oral pharmaceutical composition containing a substituted pyridylsulfinyl benzimidazole.
|
WO2000000474A1
(fr)
*
|
1998-06-26 |
2000-01-06 |
Russinsky Limited |
Blocs constitutifs de pyrimidine utilises comme intermediaires dans la synthese de composes pharmaceutiquement actifs
|
SI20019A
(sl)
*
|
1998-07-13 |
2000-02-29 |
LEK, tovarna farmacevtskih in kemi�nih izdelkov, d.d. |
Izboljšan postopek sinteze 5-metoksi -2-/(4-metoksi-3,5-dimetil-2-piridil)metil/ sulfinil-1H-benzimidazola
|
JP2002521336A
(ja)
*
|
1998-07-22 |
2002-07-16 |
セプラコール, インク. |
ヒドロキシランソプラゾールを含む医薬組成物及びその使用
|
YU10101A
(sh)
*
|
1998-08-10 |
2003-10-31 |
Partnership Of Michael E. Garst George Sachs And Jai Moo Shin |
Prolekovi inhibitori proton pumpe
|
US6093734A
(en)
*
|
1998-08-10 |
2000-07-25 |
Partnership Of Michael E. Garst, George Sachs, And Jai Moo Shin |
Prodrugs of proton pump inhibitors
|
PT1105105E
(pt)
|
1998-08-12 |
2006-07-31 |
Altana Pharma Ag |
Forma de administracao oral para piridin-2-ilmetilsulfinil-1h-benzimidazois
|
DE19843413C1
(de)
*
|
1998-08-18 |
2000-03-30 |
Byk Gulden Lomberg Chem Fab |
Neue Salzform von Pantoprazol
|
JP3926936B2
(ja)
*
|
1998-11-16 |
2007-06-06 |
エーザイ・アール・アンド・ディー・マネジメント株式会社 |
スルホキシド誘導体・アセトン錯体およびその製造法
|
US20040224989A1
(en)
*
|
1999-01-29 |
2004-11-11 |
Barberich Timothy J. |
S-lansoprazole compositions and methods
|
US6852739B1
(en)
*
|
1999-02-26 |
2005-02-08 |
Nitromed Inc. |
Methods using proton pump inhibitors and nitric oxide donors
|
TWI243672B
(en)
|
1999-06-01 |
2005-11-21 |
Astrazeneca Ab |
New use of compounds as antibacterial agents
|
DE60021570T2
(de)
|
1999-06-07 |
2006-05-24 |
Altana Pharma Ag |
Neue zubereitung und darreichungsform enthaltend einen säurelabilen protonenpumpeninhibitor
|
TWI289557B
(en)
*
|
1999-06-17 |
2007-11-11 |
Takeda Chemical Industries Ltd |
A crystal of a hydrate of (R)-2-[[[3-methyl-4-(2,2,2-trifluoroethoxy)-2-pyridyl]methyl]sulfinyl]-1H-benzimidazole
|
CA2375091A1
(fr)
*
|
1999-06-30 |
2001-01-11 |
Takeda Chemical Industries, Ltd. |
Cristaux de composes benzimidazole
|
US6245913B1
(en)
|
1999-06-30 |
2001-06-12 |
Wockhardt Europe Limited |
Synthetic procedure for 5-methoxy-2-[(4-methoxy-3,5-dimethyl-2-pyridinyl)-methylthio]-IH-benzimidazole hydrochloride and its conversion to omeprazole
|
US6369087B1
(en)
|
1999-08-26 |
2002-04-09 |
Robert R. Whittle |
Alkoxy substituted benzimidazole compounds, pharmaceutical preparations containing the same, and methods of using the same
|
US6316020B1
(en)
|
1999-08-26 |
2001-11-13 |
Robert R. Whittle |
Pharmaceutical formulations
|
US6262085B1
(en)
|
1999-08-26 |
2001-07-17 |
Robert R. Whittle |
Alkoxy substituted Benzimidazole compounds, pharmaceutical preparations containing the same, and methods of using the same
|
US6268385B1
(en)
|
1999-08-26 |
2001-07-31 |
Robert R. Whittle |
Dry blend pharmaceutical formulations
|
US6262086B1
(en)
|
1999-08-26 |
2001-07-17 |
Robert R. Whittle |
Pharmaceutical unit dosage form
|
US6326384B1
(en)
|
1999-08-26 |
2001-12-04 |
Robert R. Whittle |
Dry blend pharmaceutical unit dosage form
|
US6312723B1
(en)
|
1999-08-26 |
2001-11-06 |
Robert R. Whittle |
Pharmaceutical unit dosage form
|
US6312712B1
(en)
|
1999-08-26 |
2001-11-06 |
Robert R. Whittle |
Method of improving bioavailability
|
US6780880B1
(en)
|
1999-08-26 |
2004-08-24 |
Robert R. Whittle |
FT-Raman spectroscopic measurement
|
US6228400B1
(en)
|
1999-09-28 |
2001-05-08 |
Carlsbad Technology, Inc. |
Orally administered pharmaceutical formulations of benzimidazole derivatives and the method of preparing the same
|
KR100359256B1
(ko)
*
|
1999-10-06 |
2002-11-04 |
한미약품공업 주식회사 |
란소프라졸의 개선된 제조방법
|
SE9903831D0
(sv)
|
1999-10-22 |
1999-10-22 |
Astra Ab |
Formulation of substituted benzimidazoles
|
US20030180352A1
(en)
*
|
1999-11-23 |
2003-09-25 |
Patel Mahesh V. |
Solid carriers for improved delivery of active ingredients in pharmaceutical compositions
|
US20060034937A1
(en)
*
|
1999-11-23 |
2006-02-16 |
Mahesh Patel |
Solid carriers for improved delivery of active ingredients in pharmaceutical compositions
|
US7732404B2
(en)
|
1999-12-30 |
2010-06-08 |
Dexcel Ltd |
Pro-nanodispersion for the delivery of cyclosporin
|
SE0000774D0
(sv)
|
2000-03-08 |
2000-03-08 |
Astrazeneca Ab |
New formulation
|
ES2171116B1
(es)
*
|
2000-04-14 |
2003-08-01 |
Esteve Quimica Sa |
Procedimiento para la obtencion de derivados de (((piridil sustituido)metil)tio)bencimidazol.
|
DK1293507T3
(da)
*
|
2000-05-15 |
2007-12-27 |
Takeda Pharmaceutical |
Fremgangsmåde til fremstilling af krystaller
|
DE60123800T2
(de)
|
2000-08-04 |
2007-10-11 |
Takeda Pharmaceutical Co. Ltd. |
Salze von benzimidazol-derivaten und deren verwendung
|
US6544556B1
(en)
|
2000-09-11 |
2003-04-08 |
Andrx Corporation |
Pharmaceutical formulations containing a non-steroidal antiinflammatory drug and a proton pump inhibitor
|
WO2002026210A2
(fr)
*
|
2000-09-29 |
2002-04-04 |
Geneva Pharmaceuticals Inc. |
Formulation d'inhibiteur de la pompe à protons
|
DK1337525T3
(da)
*
|
2000-12-01 |
2011-09-19 |
Takeda Pharmaceutical |
Fremgangsmåde til krystallisering af (R)- eller (S)-lansoprazol
|
US7988999B2
(en)
|
2000-12-07 |
2011-08-02 |
Nycomed Gmbh |
Pharmaceutical preparation in the form of a paste comprising an acid-labile active ingredient
|
BR0115989A
(pt)
|
2000-12-07 |
2004-01-13 |
Altana Pharma Ag |
Preparação farmacêutica na forma de uma suspensão compreendendo um ingrediente ativo instável a ácido
|
DK1341528T3
(da)
|
2000-12-07 |
2012-03-26 |
Nycomed Gmbh |
Hurtigtopløsende tablet omfattende en syrelabil aktiv bestanddel
|
KR100430575B1
(ko)
*
|
2001-02-21 |
2004-05-10 |
주식회사 씨트리 |
란소프라졸 및 그 중간체의 제조방법
|
US6645946B1
(en)
|
2001-03-27 |
2003-11-11 |
Pro-Pharmaceuticals, Inc. |
Delivery of a therapeutic agent in a formulation for reduced toxicity
|
SE0101379D0
(sv)
|
2001-04-18 |
2001-04-18 |
Diabact Ab |
Komposition som hämmar utsöndring av magsyra
|
US8206741B2
(en)
|
2001-06-01 |
2012-06-26 |
Pozen Inc. |
Pharmaceutical compositions for the coordinated delivery of NSAIDs
|
SE0102993D0
(sv)
|
2001-09-07 |
2001-09-07 |
Astrazeneca Ab |
New self emulsifying drug delivery system
|
CN1243749C
(zh)
*
|
2001-09-18 |
2006-03-01 |
泽里新药工业株式会社 |
苯并咪唑衍生物
|
WO2003027098A1
(fr)
*
|
2001-09-25 |
2003-04-03 |
Takeda Chemical Industries, Ltd. |
Compose de benzymidazole, procede de production et d'utilisation de celui-ci
|
US9358214B2
(en)
|
2001-10-04 |
2016-06-07 |
Adare Pharmaceuticals, Inc. |
Timed, sustained release systems for propranolol
|
US8101209B2
(en)
|
2001-10-09 |
2012-01-24 |
Flamel Technologies |
Microparticulate oral galenical form for the delayed and controlled release of pharmaceutical active principles
|
PT1459737E
(pt)
|
2001-10-17 |
2012-11-26 |
Takeda Pharmaceutical |
Grânulos contendo um composto químico instável em meio ácido em concentração elevada
|
SE0104295D0
(sv)
*
|
2001-12-18 |
2001-12-18 |
Astrazeneca Ab |
New process
|
EP1492511B3
(fr)
|
2002-04-09 |
2012-05-02 |
Flamel Technologies |
Formulation pharmaceutique orale sous forme de suspension aqueuse de microcapsules permettant la liberation modifiee de principe(s) actif(s)
|
CN100577164C
(zh)
|
2002-04-09 |
2010-01-06 |
弗拉梅技术公司 |
可改进释放阿莫西林的微囊含水混悬液形式的口服药物制剂
|
US20030228363A1
(en)
*
|
2002-06-07 |
2003-12-11 |
Patel Mahendra R. |
Stabilized pharmaceutical compositons containing benzimidazole compounds
|
KR100873419B1
(ko)
*
|
2002-06-18 |
2008-12-11 |
페어차일드코리아반도체 주식회사 |
높은 항복 전압, 낮은 온 저항 및 작은 스위칭 손실을갖는 전력용 반도체 소자
|
MXPA05000657A
(es)
*
|
2002-07-19 |
2005-08-19 |
Winston Pharmaceuticals Llc |
Profarmacos de los inhibidores de bomba de protones.
|
TW200410955A
(en)
|
2002-07-29 |
2004-07-01 |
Altana Pharma Ag |
Novel salt of (S)-PANTOPRAZOLE
|
AU2003254282A1
(en)
*
|
2002-08-01 |
2004-02-23 |
Nitromed, Inc. |
Nitrosated proton pump inhibitors, compositions and methods of use
|
AU2003258335A1
(en)
*
|
2002-08-21 |
2004-03-11 |
Teva Pharmaceutical Industries Ltd. |
A method for the purification of lansoprazole
|
WO2004019955A1
(fr)
|
2002-08-30 |
2004-03-11 |
Altana Pharma Ag |
Utilisation de la combinaison de ciclesonide et d'antihistaminiques pour le traitement de la rhinite allergique
|
SE0203065D0
(sv)
|
2002-10-16 |
2002-10-16 |
Diabact Ab |
Gastric acid secretion inhibiting composition
|
MY148805A
(en)
|
2002-10-16 |
2013-05-31 |
Takeda Pharmaceutical |
Controlled release preparation
|
AU2003273000A1
(en)
*
|
2002-10-16 |
2004-05-04 |
Takeda Pharmaceutical Company Limited |
Stable solid preparations
|
EP1743893A1
(fr)
|
2002-11-18 |
2007-01-17 |
Teva Pharmaceutical Industries Ltd. |
Lansoprazole stable contenant plus de 500 parties par million, jusqu'à environ 3000 parties par million d'eau et plus de 200 parties par million, jusqu'à environ 5000 parties par million d'alcool
|
US7683080B2
(en)
*
|
2002-11-18 |
2010-03-23 |
Teva Pharmaceutical Industries Ltd. |
Stable iansoprazole containing more than 500 ppm, up to about 3,000 ppm water and more than 200 ppm, up to about 5,000 ppm alcohol
|
DE10254167A1
(de)
|
2002-11-20 |
2004-06-09 |
Icon Genetics Ag |
Verfahren zur Kontrolle von zellulären Prozessen in Pflanzen
|
CA2507889C
(fr)
|
2002-12-06 |
2012-02-07 |
Altana Pharma Ag |
Procede de preparation de (s)-pantoprazole
|
PL375818A1
(en)
|
2002-12-06 |
2005-12-12 |
Altana Pharma Ag |
Process for preparing optically pure active compounds
|
CA2510849A1
(fr)
*
|
2002-12-19 |
2004-07-08 |
Teva Pharmaceutical Industries Ltd |
Etats solides de sodium de pantoprazole, leurs procedes de preparation et procedes de preparation d'hydrates de sodium de pantoprazole connus
|
US8367111B2
(en)
|
2002-12-31 |
2013-02-05 |
Aptalis Pharmatech, Inc. |
Extended release dosage forms of propranolol hydrochloride
|
CA2515130A1
(fr)
*
|
2003-02-05 |
2004-08-26 |
Teva Pharmaceutical Industries Ltd. |
Procede de stabilisation de lansoprazole
|
US20050220870A1
(en)
*
|
2003-02-20 |
2005-10-06 |
Bonnie Hepburn |
Novel formulation, omeprazole antacid complex-immediate release for rapid and sustained suppression of gastric acid
|
WO2004080439A1
(fr)
*
|
2003-03-12 |
2004-09-23 |
Takeda Pharmaceutical Company Limited |
Composition de medicament comportant un principe actif adhere en concentration elevee a un noyau spherique
|
EP1601667A2
(fr)
*
|
2003-03-12 |
2005-12-07 |
Teva Pharmaceutical Industries Limited |
Formes solides cristallines et amorphes de pantoprazole et procedes de preparation de ces formes
|
JP4355703B2
(ja)
*
|
2003-03-13 |
2009-11-04 |
エーザイ・アール・アンド・ディー・マネジメント株式会社 |
歯ぎしりの予防剤または治療剤
|
CA2523218A1
(fr)
*
|
2003-04-22 |
2004-11-04 |
Dr. Reddy's Laboratories Limited |
Formulations pharmaceutiques orales a base de principes actifs labiles en milieu acide et de derives glucides hydrosolubles, utilisation de ces formulations, et procede de fabrication approprie
|
CL2004000983A1
(es)
|
2003-05-08 |
2005-03-04 |
Altana Pharma Ag |
Composicion farmaceutica oral en forma de tableta que comprende a pantoprazol magnetico dihidratado, en donde la forma de tableta esta compuesto por un nucleo, una capa intermedia y una capa exterior; y uso de la composicion farmaceutica en ulceras y
|
PE20050150A1
(es)
|
2003-05-08 |
2005-03-22 |
Altana Pharma Ag |
Una forma de dosificacion que contiene (s)-pantoprazol como ingrediente activo
|
EP1615913A2
(fr)
*
|
2003-06-10 |
2006-01-18 |
Teva Pharmaceutical Industries Limited |
Procede de preparation de benzimidazoles 2- (pyridinyl)methyl]sulfinyle substitues et nouveau derives chlorures de pantoprazole
|
CA2529984C
(fr)
*
|
2003-06-26 |
2012-09-25 |
Isa Odidi |
Capsules contenant un inhibiteur de la pompe a protons comprenant des unites secondaires differemment structurees permettant une liberation retardee de l'ingredient actif
|
WO2005016917A1
(fr)
*
|
2003-07-15 |
2005-02-24 |
Allergan, Inc. |
Procede de preparation de promedicaments isomeriquement purs d'inhibiteurs de la pompe a protons
|
US8993599B2
(en)
|
2003-07-18 |
2015-03-31 |
Santarus, Inc. |
Pharmaceutical formulations useful for inhibiting acid secretion and methods for making and using them
|
JP2007504261A
(ja)
*
|
2003-09-03 |
2007-03-01 |
エイジーアイ・セラピューティクス・リサーチ・リミテッド |
プロトンポンプ阻害剤製剤、並びに当該製剤を製造及び使用する方法関連出願の表示
|
TWI372066B
(en)
|
2003-10-01 |
2012-09-11 |
Wyeth Corp |
Pantoprazole multiparticulate formulations
|
US20050075371A1
(en)
*
|
2003-10-03 |
2005-04-07 |
Allergan, Inc. |
Methods and compositions for the oral administration of prodrugs of proton pump inhibitors
|
WO2005039640A1
(fr)
*
|
2003-10-03 |
2005-05-06 |
Allergan Inc. |
Compositions contenant des peptides en trefle et/ou des mucoadhesifs et des promedicaments d'un inhibiteur de pompe a proton
|
WO2005076987A2
(fr)
*
|
2004-02-10 |
2005-08-25 |
Santarus, Inc. |
Combinaison d'un inhibiteur de la pompe a protons, d'un tampon et d'un medicament anti-inflammatoire non steroidien
|
GB0403165D0
(en)
*
|
2004-02-12 |
2004-03-17 |
Ct |
Novel uses for proton pump inhibitors
|
US20070161679A1
(en)
*
|
2004-02-18 |
2007-07-12 |
Allergan, Inc. |
Method and compositions for the intravenous administration of compounds related to proton pump inhibitors
|
AU2005216862A1
(en)
*
|
2004-02-18 |
2005-09-09 |
Allergan, Inc. |
Compositions comprising prodrugs of proton pump inhibitors
|
CN1964704A
(zh)
*
|
2004-03-03 |
2007-05-16 |
特瓦制药工业有限公司 |
包含酸不稳定药物的稳定药用组合物
|
CA2561700A1
(fr)
*
|
2004-04-16 |
2005-12-15 |
Santarus, Inc. |
Combinaison d'un inhibiteur de la pompe a protons, d'un agent tampon et d'un agent prokinetique
|
US20070219236A1
(en)
*
|
2004-04-28 |
2007-09-20 |
Atlanta Pharma Ag |
Dialkoxy-Imidazopyridines Derivatives
|
US8815916B2
(en)
|
2004-05-25 |
2014-08-26 |
Santarus, Inc. |
Pharmaceutical formulations useful for inhibiting acid secretion and methods for making and using them
|
US8906940B2
(en)
|
2004-05-25 |
2014-12-09 |
Santarus, Inc. |
Pharmaceutical formulations useful for inhibiting acid secretion and methods for making and using them
|
JP5563735B2
(ja)
|
2004-06-16 |
2014-07-30 |
タケダ ファーマシューティカルズ ユー.エス.エー. インコーポレイティド |
Ppi多回剤形
|
US8394409B2
(en)
|
2004-07-01 |
2013-03-12 |
Intellipharmaceutics Corp. |
Controlled extended drug release technology
|
US20060024362A1
(en)
|
2004-07-29 |
2006-02-02 |
Pawan Seth |
Composition comprising a benzimidazole and process for its manufacture
|
US10624858B2
(en)
|
2004-08-23 |
2020-04-21 |
Intellipharmaceutics Corp |
Controlled release composition using transition coating, and method of preparing same
|
US8747895B2
(en)
|
2004-09-13 |
2014-06-10 |
Aptalis Pharmatech, Inc. |
Orally disintegrating tablets of atomoxetine
|
EP2264025B1
(fr)
|
2004-09-13 |
2013-11-06 |
Takeda Pharmaceutical Company Limited |
Procédé de production de lansoprazole
|
US9884014B2
(en)
|
2004-10-12 |
2018-02-06 |
Adare Pharmaceuticals, Inc. |
Taste-masked pharmaceutical compositions
|
MX2007004741A
(es)
|
2004-10-21 |
2007-09-07 |
Eurand Pharmaceuticals Ltd |
Composiciones farmaceuticas con sabor enmascarado con formadores de poro gastrosolubles.
|
US20060105038A1
(en)
*
|
2004-11-12 |
2006-05-18 |
Eurand Pharmaceuticals Limited |
Taste-masked pharmaceutical compositions prepared by coacervation
|
EP2417986A1
(fr)
|
2004-11-22 |
2012-02-15 |
Anadis Ltd. |
Compositions bioactives
|
EP1681056A1
(fr)
|
2005-01-14 |
2006-07-19 |
Krka Tovarna Zdravil, D.D., Novo Mesto |
Procédé de préparation du lansoprazole
|
EP1852100B1
(fr)
|
2005-02-25 |
2018-05-09 |
Takeda Pharmaceutical Company Limited |
Procédé de fabrication de granulés enrobés du benzimidazole
|
KR100771659B1
(ko)
|
2005-03-23 |
2007-10-30 |
주식회사 카이로제닉스 |
판토프라졸 및 그 중간체의 제조방법
|
US9161918B2
(en)
|
2005-05-02 |
2015-10-20 |
Adare Pharmaceuticals, Inc. |
Timed, pulsatile release systems
|
US7803817B2
(en)
|
2005-05-11 |
2010-09-28 |
Vecta, Ltd. |
Composition and methods for inhibiting gastric acid secretion
|
US7981908B2
(en)
|
2005-05-11 |
2011-07-19 |
Vecta, Ltd. |
Compositions and methods for inhibiting gastric acid secretion
|
WO2006132217A1
(fr)
|
2005-06-07 |
2006-12-14 |
Takeda Pharmaceutical Company Limited |
Cristal d'un sel d'un compose de benzimidazole
|
US20090036406A1
(en)
*
|
2005-06-13 |
2009-02-05 |
Takeda Pharmaceutical Company Limited |
Injection
|
US7601737B2
(en)
|
2005-07-26 |
2009-10-13 |
Nycomed Gmbh |
Isotopically substituted proton pump inhibitors
|
CA2624179A1
(fr)
*
|
2005-10-06 |
2007-04-12 |
Auspex Pharmaceuticals, Inc. |
Inhibiteurs deuteries d'atpase h+,k+ gastrique ayant des proprietes therapeutiques renforcees
|
GB0525710D0
(en)
*
|
2005-12-17 |
2006-01-25 |
Pliva Hrvatska D O O |
An improved process for preparing of substituted 2-benzimidazolesulfoxide compounds
|
US10064828B1
(en)
|
2005-12-23 |
2018-09-04 |
Intellipharmaceutics Corp. |
Pulsed extended-pulsed and extended-pulsed pulsed drug delivery systems
|
JP5053865B2
(ja)
|
2005-12-28 |
2012-10-24 |
武田薬品工業株式会社 |
口腔内崩壊性固形製剤の製造法
|
EP1967183A4
(fr)
|
2005-12-28 |
2011-02-23 |
Takeda Pharmaceutical |
Preparation solide a liberation controlee
|
SI2003130T1
(sl)
*
|
2006-03-10 |
2012-02-29 |
Arigen Pharmaceuticals Inc |
Nov piridinski derivat, ki ima aktivnost proti Helicobacter pylori
|
EP2007360B1
(fr)
|
2006-04-03 |
2014-11-26 |
Isa Odidi |
Dispositif d'administration à libération commandée comprenant un enrobage organosol
|
US10960077B2
(en)
|
2006-05-12 |
2021-03-30 |
Intellipharmaceutics Corp. |
Abuse and alcohol resistant drug composition
|
WO2007138606A2
(fr)
*
|
2006-06-01 |
2007-12-06 |
Dexcel Pharma Technologies Ltd. |
Formulation pharmaceutique comprenant des unités multiples
|
US7863330B2
(en)
|
2006-06-14 |
2011-01-04 |
Rottapharm S.P.A. |
Deloxiglumide and proton pump inhibitor combination in the treatment of gastrointestinal disorders
|
JP5474541B2
(ja)
|
2006-07-25 |
2014-04-16 |
ベクタ・リミテッド |
小さいジカルボン酸の誘導体と組み合わせてppiを用いる胃酸分泌を阻害する組成物および方法
|
US20100317689A1
(en)
*
|
2006-09-19 |
2010-12-16 |
Garst Michael E |
Prodrugs of proton pump inhibitors including the 1h-imidazo[4,5-b] pyridine moiety
|
WO2008035189A1
(fr)
*
|
2006-09-22 |
2008-03-27 |
Orchid Chemicals & Pharmaceuticals Limited |
Procédé de purification du lansoprazole
|
CA2665226C
(fr)
|
2006-10-05 |
2014-05-13 |
Santarus, Inc. |
Nouvelles formulations pour une liberation immediate d'inhibiteurs de pompe a protons et procedes d'utilisation de ces formulations
|
CA2667682A1
(fr)
|
2006-10-27 |
2008-05-15 |
The Curators Of The University Of Missouri |
Compositions comprenant des agents d'inhibition de la pompe a protons labiles d'acide, au moins un autre agent pharmaceutiquement actif et leurs procedes d'utilisation
|
JP2010514702A
(ja)
|
2006-12-22 |
2010-05-06 |
アイロンウッド ファーマシューティカルズ,インコーポレーテッド |
食道障害の治療方法および治療用組成物
|
US9486446B2
(en)
|
2006-12-28 |
2016-11-08 |
Takeda Pharmaceutical Company Limited |
Orally disintegrating solid preparation
|
WO2008087665A2
(fr)
*
|
2007-01-18 |
2008-07-24 |
Matrix Laboratories Ltd |
Procédé de préparation de lansoprazole
|
US20080194307A1
(en)
*
|
2007-02-13 |
2008-08-14 |
Jeff Sanger |
Sports-based game of chance
|
TW200840574A
(en)
*
|
2007-04-02 |
2008-10-16 |
Univ Nat Taiwan |
The pharmaceutical component for treating hearing loss disease
|
WO2009010937A1
(fr)
|
2007-07-17 |
2009-01-22 |
Ranbaxy Laboratories Limited |
Procédé de préparation de pantoprazole sodique.
|
CN102014638A
(zh)
|
2007-10-12 |
2011-04-13 |
武田制药北美公司 |
与食物摄入无关的治疗胃肠病症的方法
|
NZ593629A
(en)
*
|
2007-12-18 |
2012-11-30 |
Watson Pharma Private Ltd |
Stable amorphous R-lansoprazole prepared by optically resolving racemic lansoprazole
|
EP2292612A3
(fr)
|
2007-12-31 |
2011-05-04 |
Takeda Pharmaceutical Company Limited |
Formes dissoutes cristallines de (R) -2-[[[3-méthyl-4- (2, 2, 2-trifluoroéthoxy) -2-pyridinyl]méthyl]sulfinyl]-1h-benzimidazole
|
CA2716367C
(fr)
|
2008-02-20 |
2015-05-26 |
The Curators Of The University Of Missouri |
Composition comprenant une combinaison d'omeprazole et de lansoprazole, et un agent tampon, et ses methodes d'utilisation
|
US20090227633A1
(en)
*
|
2008-03-04 |
2009-09-10 |
Bassam Damaj |
Methods to inhibit tumor cell growth by using proton pump inhibitors
|
GEP20125649B
(en)
|
2008-03-10 |
2012-09-25 |
Takeda Pharmaceutical |
Benzimidazole compound crystal
|
US20090263475A1
(en)
*
|
2008-04-21 |
2009-10-22 |
Nagaraju Manne |
Dexlansoprazole compositions
|
US8362042B2
(en)
|
2008-05-14 |
2013-01-29 |
Watson Pharma Private Limited |
Stable R(+)-lansoprazole amine salt and a process for preparing the same
|
AU2009290712A1
(en)
|
2008-09-09 |
2010-03-18 |
Astrazeneca Ab |
Method for delivering a pharmaceutical composition to patient in need thereof
|
US20100113527A1
(en)
*
|
2008-09-30 |
2010-05-06 |
Teva Pharmaceutical Industries Ltd. |
Crystalline forms of dexlansoprazole
|
WO2010042785A1
(fr)
*
|
2008-10-10 |
2010-04-15 |
Celtaxsys, Inc. |
Procédé d’induction d’un chimiotactisme négatif
|
US11304960B2
(en)
|
2009-01-08 |
2022-04-19 |
Chandrashekar Giliyar |
Steroidal compositions
|
WO2010122583A2
(fr)
|
2009-04-24 |
2010-10-28 |
Rubicon Research Private Limited |
Compositions pharmaceutiques orales comprenant des substances labiles en milieu acide
|
WO2010134099A1
(fr)
|
2009-05-21 |
2010-11-25 |
Cadila Healthcare Limited |
Procédé de préparation dans un récipient unique d'oméprazole
|
WO2011004387A2
(fr)
|
2009-06-18 |
2011-01-13 |
Matrix Laboratories Ltd |
Procédé de préparation de formes polymorphes du dexlansoprazole
|
EP2445499A4
(fr)
|
2009-06-25 |
2013-02-27 |
Astrazeneca Ab |
Procede pour le traitement d'un patient a risque de developer un ulcere associe a nsaid
|
TWI471146B
(zh)
|
2009-12-02 |
2015-02-01 |
Aptalis Pharma Ltd |
菲索特芬那定(fexofenadine)微膠囊及包含其之組合物
|
WO2011080500A2
(fr)
|
2009-12-29 |
2011-07-07 |
Orexo Ab |
Nouvelle forme pharmaceutique destinée au traitement de troubles liés à l'acide gastrique
|
EP2519229A2
(fr)
|
2009-12-29 |
2012-11-07 |
Novartis AG |
Nouvelle forme pharmaceutique destinée au traitement de troubles liés à l'acide gastrique
|
WO2011080502A2
(fr)
|
2009-12-29 |
2011-07-07 |
Orexo Ab |
Nouvelle forme pharmaceutique destinée au traitement de troubles liés à l'acide gastrique
|
US20110212171A1
(en)
*
|
2010-01-08 |
2011-09-01 |
Eurand, Inc. |
Taste masked topiramate composition and an orally disintegrating tablet comprising the same
|
US20110189271A1
(en)
*
|
2010-02-02 |
2011-08-04 |
Vishal Lad |
Pharmaceutical formulations of acid-labile drugs
|
US20130202688A1
(en)
|
2010-05-04 |
2013-08-08 |
Sunilendu Bhushan Roy |
Delayed release oral disintegrating pharmaceutical compositions of lansoprazole
|
US20130216617A1
(en)
|
2010-06-29 |
2013-08-22 |
Cadila Healthcare Limited |
Pharmaceutical compositions of (r)-lansoprazole
|
US20130156720A1
(en)
|
2010-08-27 |
2013-06-20 |
Ironwood Pharmaceuticals, Inc. |
Compositions and methods for treating or preventing metabolic syndrome and related diseases and disorders
|
US9358241B2
(en)
|
2010-11-30 |
2016-06-07 |
Lipocine Inc. |
High-strength testosterone undecanoate compositions
|
US9034858B2
(en)
|
2010-11-30 |
2015-05-19 |
Lipocine Inc. |
High-strength testosterone undecanoate compositions
|
US20180153904A1
(en)
|
2010-11-30 |
2018-06-07 |
Lipocine Inc. |
High-strength testosterone undecanoate compositions
|
PE20140005A1
(es)
|
2010-12-03 |
2014-01-23 |
Takeda Pharmaceutical |
Tableta oralmente desintegradora
|
US20120148675A1
(en)
|
2010-12-10 |
2012-06-14 |
Basawaraj Chickmath |
Testosterone undecanoate compositions
|
MX2013007588A
(es)
|
2010-12-27 |
2013-08-09 |
Takeda Pharmaceutical |
Comprimido de desintegracion oral.
|
US9233103B2
(en)
|
2011-03-25 |
2016-01-12 |
Takeda Pharmaceuticals U.S.A., Inc. |
Methods for treating heartburn, gastric bleeding or hemorrhage in patients receiving clopidogrel therapy
|
TWI630002B
(zh)
|
2011-11-30 |
2018-07-21 |
武田藥品工業股份有限公司 |
乾塗覆錠
|
EP2601947A1
(fr)
|
2011-12-05 |
2013-06-12 |
Abo Bakr Mohammed Ali Al-Mehdar |
Combinaison à dose fixe pour le traitement de maladies associées à Hélicobacter pylori
|
CN104114169A
(zh)
|
2011-12-16 |
2014-10-22 |
阿托佩斯治疗有限公司 |
用于治疗嗜酸细胞性食管炎的crth2拮抗剂和质子泵抑制剂的组合物
|
UA115139C2
(uk)
|
2011-12-28 |
2017-09-25 |
Поузен Інк. |
Спосіб доставки фармацевтичної композиції, яка містить омепразол й ацетилсаліцилову кислоту, пацієнту
|
WO2013108068A1
(fr)
|
2012-01-21 |
2013-07-25 |
Jubilant Life Sciences Limited |
Procédé de préparation de 2-pyridinylméthylsulfinylbenzimidazoles, leurs analogues et énantiomères optiquement actifs
|
CN105338958A
(zh)
|
2013-01-15 |
2016-02-17 |
铁木医药有限公司 |
胆汁酸螯合剂的胃内滞留缓释口服剂型
|
KR20160010595A
(ko)
|
2013-05-21 |
2016-01-27 |
다케다 야쿠힌 고교 가부시키가이샤 |
구강내 붕괴정
|
US9457011B2
(en)
|
2014-02-25 |
2016-10-04 |
Muslim D. Shahid |
Compositions and methods for the treatment of acid-related gastrointestinal disorders containing a dithiolane compound and a gastric acid secretion inhibitor
|
WO2016033549A2
(fr)
|
2014-08-28 |
2016-03-03 |
Lipocine Inc. |
Compositions de (17-ss)-3-oxoandrost-4-èn-17-yl tridécanoate et leurs procédés de préparation et d'utilisation
|
WO2016033556A1
(fr)
|
2014-08-28 |
2016-03-03 |
Lipocine Inc. |
Esters de (17-β)-hydroxy-4-androstène-3-one biodisponibles à l'état solide
|
WO2016126625A1
(fr)
|
2015-02-03 |
2016-08-11 |
Ironwood Pharmaceuticals, Inc. |
Méthodes de traitement de troubles gastro-intestinaux supérieurs de gerd réfractaire à ppi
|
EP3288556A4
(fr)
|
2015-04-29 |
2018-09-19 |
Dexcel Pharma Technologies Ltd. |
Compositions à désintégration par voie orale
|
US10736855B2
(en)
|
2016-02-25 |
2020-08-11 |
Dexcel Pharma Technologies Ltd. |
Compositions comprising proton pump inhibitors
|
US10076494B2
(en)
|
2016-06-16 |
2018-09-18 |
Dexcel Pharma Technologies Ltd. |
Stable orally disintegrating pharmaceutical compositions
|
US20180147215A1
(en)
|
2016-11-28 |
2018-05-31 |
Lipocine Inc. |
Oral testosterone undecanoate therapy
|
CN107365300B
(zh)
*
|
2017-07-26 |
2019-08-02 |
桂林华信制药有限公司 |
一种有效去除兰索拉唑粗品中杂质的方法
|
CN114163419A
(zh)
*
|
2021-12-24 |
2022-03-11 |
辰欣药业股份有限公司 |
一种兰索拉唑的制备方法
|
WO2024075017A1
(fr)
|
2022-10-04 |
2024-04-11 |
Zabirnyk Arsenii |
Inhibition de calcification de valve aortique
|